TABLE 4.
DAPr strain(s) | Source | Increased positive surface charge | Potential mechanism(s) of increased positive surface | Genetic factor(s) potentially involved in surface charge alterations | CW thickness | Reference |
---|---|---|---|---|---|---|
CB2205 (MRSA MW2 USA 400) | In vitro selection by serial passage in DAP | No | NAa | NA | ↑b | 16 |
701, 703 (MSSAc) | Clinical isolates - endocarditis | Yes | Increased LPG translocation to outer membrane leaflet | Increased mprF transcription (stationary phase), S295L point mutation | ↑ | 11, 37 |
BOY300 (MSSA) | Clinical isolate - endocarditis | Yes | Increased teichoic acid alanylation | Increased dlt transcription | ↑ | 36 |
MRSA 11/21, REF2145 (MRSA USA 300) | Clinical isolates - endocarditis | Yes | Increased total LPG synthesis | Increased mprF transcription (exponential phase), T345A point mutation | Equivalent | This study |
NA, not applicable.
↑, increased.
MSSA, methicillin-susceptible S. aureus.